JPRN-UMIN000023591已完成未知
Feasibility study of neoadjuvant gemcitabine plus nab-paclitaxel for borderline resectable pancreatic cancer - Feasibility study of NAC GEM+nab-PTX for BRPC
Kyorin University, School of Medicine0 个研究点目标入组 10 人开始时间: 2016年8月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) With pulmonary fibrosis or interstitial pneumonia 2) With active double cancers 3) With severe complications such as heart failure, bowel obstruction and uncontrollable diabetes millitus 4) With active infection 5) Pregnant or lactating women or women of childbearing potential and men who want to get partner pregnant 6) Psychosis or severe mental disorder 7) Recieving systemic steroid therapy 8) With severe drug allergy
研究者
相似试验
进行中（未招募）
1 期
Feasibility and efficacy of adjuvant gemcitabine chemotherapy after liver transplantation for proximal bile duct cancer - pro-ductEUCTR2010-020480-21-DEniversitätsmedizin Charite45
招募中
2 期
Feasibility and efficacy of adjuvant gemcitabine chemotherapy after liver transplantation for proximal bile duct cancerMedDRA - 9373BILEDUCTCANCERSTAGEIMedDRA - 10059374: Bile duct cancer stage IIC24.0C24.8Extrahepatic bile ductOverlapping lesion of biliary tractDRKS00000805Charité Campus Virchow-Klinikum60
已完成
不适用
Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic CancerResectable Pancreatic CancersNCT02318095Duke University40
招募中
2 期
A phase II clinical trial of neoadjuvant gemcitabine and S-1 with concurrent radiotherapy in patients with resectable and borderline resectable pancreatic ductal adenocarcinomaresectable and borderline resectable (BR-PV) pancreatic cancerJPRN-UMIN000053195Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University64
招募中
2 期
A phase II clinical trial of neoadjuvant gemcitabine and S-1 with concurrent hypofractionated radiotherapy in patients with resectable and borderline resectable pancreatic ductal adenocarcinomaresectable and borderline resectable (BR-PV) pancreatic cancerJPRN-UMIN000038585Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University54